Endometrial polypoid adenomyoma outcomes and fertility-sparing treatments efficacy for atypical type: A systematic review and network meta-analysis

Table 1 Rankings of interventions based on surface under the cumulative ranking curve analysis

Treatment	SUCRA (%)	PrBest (%)	Mean rank
TCRP	40.9	16.8	8.3
TCRP + HDP	49.9	15.8	7
TCRP + MPA (10 mg/day)	78.3	5.7	3.6
TCRP + COC	56.1	10	6.3
TCRP + LNG-IUS	66	14.7	5.1
TCRP + PT	42.3	10.3	7.9
TCRE	54.3	1.1	6.5
TCRE + PT	51.3	4.1	6.9
PWH	38.2	2.6	8.4
PWH + HDP	50.2	1	7
PWH + HDP + MT	49	3.8	7.1
LNG-IUS	40.3	10.1	8.2
PT	43.1	4	7.8

SUCRA: Surface under the cumulative ranking curve; PrBest: Probability of being the best; TCRP: Transcervical resection of polyps; LNG-IUS: Levonorgestrel-releasing intrauterine system; COC: Combined oral contraceptive; PT: Progesterone therapy; MPA: Medroxyprogesterone acetate; TCRE: Transcervical resection of endometrium; PWH: Polyp resection without hysteroscopy; HDP: High-dose progestin; MT: Hormone maintenance therapy.